GoAI
Get started
SenesTech, Inc. logo

SenesTech, Inc.

SNES

NASDAQBasic MaterialsChemicals - Specialty

Open in GoAI

Regular session

$1.195

−$0.065 · -5.16%

Aug 24, 11:11 AM ET

SNES company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

65

Undervalued

Momentum

23

Weakening

Sentiment

64

Bullish

Risk resilience

34

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption. It also develops Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice. The company was incorporated in 2004 and is headquartered in Surprise, Arizona.

Industry
Chemicals - Specialty
Sector
Basic Materials
Headquarters
US
CEO
Michael Edell
Listed since
Dec 7, 2016
Employees
24

Market position

Day range

Current $1.195

52-week range

Current $1.195

Open
$1.25
Previous close
$1.26
Volume
30.08K
0.34× average
Average volume
89.27K
Average daily volume
Market cap
6.34M USD
Beta
0.26
Market reference 1
50-day average
$1.431
-16.49% below average
200-day average
$1.914
-37.57% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
65.21M USD
P/E (TTM)
-0.87×
P/B (TTM)
1.05×
P/S (TTM)
2.67×
EV / EBITDA
-10.47×
Earnings yield
-9.10%
Free cash flow yield
-8.40%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
64.91%
Operating margin
-303.66%
Net margin
-294.73%
Return on equity
-66.71%
Return on assets
-49.70%
Return on invested capital
-53.12%

Financial health

Debt / equity
0.43×
Current ratio
12.61×
Altman Z-score
-22.07
Piotroski F-score
3 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends224%-422%-1067%-1712%Gross margin, FY2021: 38.19%Gross margin, FY2022: 45.53%Gross margin, FY2023: 45.18%Gross margin, FY2024: 54.07%Gross margin, FY2025: 62.49%Operating margin, FY2021: -1551.04%Operating margin, FY2022: -949.36%Operating margin, FY2023: -648.11%Operating margin, FY2024: -336.51%Operating margin, FY2025: -292.89%Net margin, FY2021: -1435.42%Net margin, FY2022: -951.42%Net margin, FY2023: -646.27%Net margin, FY2024: -333.01%Net margin, FY2025: -287.39%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 38.19%. Gross margin FY2022 45.53%. Gross margin FY2023 45.18%. Gross margin FY2024 54.07%. Gross margin FY2025 62.49%. Operating margin FY2021 -1551.04%. Operating margin FY2022 -949.36%. Operating margin FY2023 -648.11%. Operating margin FY2024 -336.51%. Operating margin FY2025 -292.89%. Net margin FY2021 -1435.42%. Net margin FY2022 -951.42%. Net margin FY2023 -646.27%. Net margin FY2024 -333.01%. Net margin FY2025 -287.39%.

Income trends

Revenue

2.22M USD+19.60%

Operating income

−6.51M USD-4.10%

Net income

−6.38M USD-3.22%
Income trends across reported periods3.41M USD−1.35M USD−6.12M USD−10.89M USDRevenue, FY2021: 576K USDRevenue, FY2022: 1.02M USDRevenue, FY2023: 1.19M USDRevenue, FY2024: 1.86M USDRevenue, FY2025: 2.22M USDOperating income, FY2021: −8.93M USDOperating income, FY2022: −9.67M USDOperating income, FY2023: −7.73M USDOperating income, FY2024: −6.25M USDOperating income, FY2025: −6.51M USDNet income, FY2021: −8.27M USDNet income, FY2022: −9.7M USDNet income, FY2023: −7.71M USDNet income, FY2024: −6.18M USDNet income, FY2025: −6.38M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 576K USD. Revenue FY2022 1.02M USD. Revenue FY2023 1.19M USD. Revenue FY2024 1.86M USD. Revenue FY2025 2.22M USD. Operating income FY2021 −8.93M USD. Operating income FY2022 −9.67M USD. Operating income FY2023 −7.73M USD. Operating income FY2024 −6.25M USD. Operating income FY2025 −6.51M USD. Net income FY2021 −8.27M USD. Net income FY2022 −9.7M USD. Net income FY2023 −7.71M USD. Net income FY2024 −6.18M USD. Net income FY2025 −6.38M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue2.22M USD1.86M USD1.19M USD1.02M USD576K USD
Cost of goods sold833K USD853K USD654K USD555K USD356K USD
Gross profit1.39M USD1M USD539K USD464K USD220K USD
Research and development1.7M USD1.71M USD1.23M USD1.86M USD1.95M USD
Selling, general, and administrative6.2M USD5.54M USD7.02M USD8.22M USD7.18M USD
Operating expenses7.89M USD7.25M USD8.27M USD10.14M USD9.15M USD
Interest income144K USD56K USD26K USD7K USD4K USD
Interest expense22K USD22K USD4K USD2K USD11K USD
Depreciation and amortization135K USD156K USD135K USD183K USD303K USD
Operating income−6.51M USD−6.25M USD−7.73M USD−9.67M USD−8.93M USD
Net income−6.38M USD−6.18M USD−7.71M USD−9.7M USD−8.27M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
78%
7 beats, 2 misses, 0 met estimates
Average EPS surprise
-2.13%
9 comparable reports
Latest EPS result
-0.35
Estimate -0.37 · Beat by 4.11%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates-0.24-0.69-1.14-1.6Q1 '25BeatQ2 '25No estimateQ3 '25No estimateQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Mar 12, 2025: actual -1.22, estimate -1.5, surprise +18.67%, Beat. Q2 2025, reported May 8, 2025: actual -1.28, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 7, 2025: actual -0.87, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 10, 2025: actual -0.28, estimate -0.35, surprise +20.00%, Beat. Q1 2026, reported Mar 12, 2026: actual -0.29, estimate -0.3, surprise +3.33%, Beat. Q2 2026, reported May 12, 2026: actual -0.31, estimate -0.33, surprise +6.06%, Beat. Q3 2026, reported Aug 5, 2026: actual -0.35, estimate -0.365, surprise +4.11%, Beat. Q4 2026, reported Nov 9, 2026: actual —, estimate -0.33, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates828.88K682.29K535.71K389.12KQ1 '25MissQ2 '25No estimateQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26MissQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Mar 12, 2025: actual 501K USD, estimate 707K USD, surprise -29.14%, Miss. Q2 2025, reported May 8, 2025: actual 485K USD, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 7, 2025: actual 625K USD, estimate 730K USD, surprise -14.38%, Miss. Q4 2025, reported Nov 10, 2025: actual 690K USD, estimate 776K USD, surprise -11.08%, Miss. Q1 2026, reported Mar 12, 2026: actual 421K USD, estimate 776K USD, surprise -45.75%, Miss. Q2 2026, reported May 12, 2026: actual 493K USD, estimate 632K USD, surprise -21.99%, Miss. Q3 2026, reported Aug 5, 2026: actual 770K USD, estimate 601.5K USD, surprise +28.01%, Beat. Q4 2026, reported Nov 9, 2026: actual —, estimate 797K USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Recent analyst actions

1 institution

SNES news

prnewswire.com

SenesTech to Participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 2026

SURPRISE, Ariz., Aug. 17, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in fertility control for managing animal pest populations, today announced that it will participate in a webcast presentation at the…

Read source
defenseworld.net

Financial Survey: Senestech (NASDAQ:SNES) & Chemtrade Logistics Income Fund (OTCMKTS:CGIFF)

Chemtrade Logistics Income Fund (OTCMKTS:CGIFF - Get Free Report) and Senestech (NASDAQ: SNES - Get Free Report) are both materials companies, but which is the better stock? We will compare the two businesses based on…

Read source
seekingalpha.com

SenesTech, Inc. (SNES) Q2 2026 Earnings Call Transcript

SenesTech, Inc. (SNES) Q2 2026 Earnings Call Transcript

Read source
defenseworld.net

Senestech Q2 Earnings Call Highlights

SenesTech (NASDAQ: SNES) reported second-quarter 2026 revenue of $770,000, a company record and an increase of 56% from the first quarter and 23% from the prior-year period, as direct management of its Amazon and other…

Read source
prnewswire.com

SenesTech Reports Record Q2 2026 Revenue and Gross Margin as E-commerce Growth Accelerates

Revenue rose 56% sequentially and gross margin reached a company-record 73.6% in the first full quarter of in-house Amazon management, advancing the Company's intended shift to a scalable, recurring-revenue platform.…

Read source
prnewswire.com

SenesTech Adds Assessment Services to Help B2B Customers Better Understand Rodent Infestations

New assessment services complement existing implementation and deployment services to develop the most effective solution for each customer's rodent problem. SURPRISE, Ariz.

Read source

Corporate actions

Corporate action history

Stock split

Effective Jul 25, 2024

1:10

Stock split

Effective Nov 17, 2023

1:12

Stock split

Effective Nov 16, 2022

1:20

Stock split

Effective Feb 5, 2020

1:20

ETFs holding SNES

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
46.93K
Weight
0.00%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$244.04-0.61%

Continue in GoAI

Research SNES

research.disclaimer